SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
The metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. Recent studies showed that serine hydroxymethyltransferase 2 (SHMT2), a crucial enzyme in the one-carbon metabolic pathway, plays a key role in tum...
Main Authors: | Weida Wang, Mingjin Wang, Tingting Du, Zhenyan Hou, Shen You, Sen Zhang, Ming Ji, Nina Xue, Xiaoguang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7150 |
Similar Items
-
Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
by: Jun Li, et al.
Published: (2023-04-01) -
Knockdown of SHMT2 enhances the sensitivity of gastric cancer cells to radiotherapy through the Wnt/β-catenin pathway
by: Mao Yu, et al.
Published: (2022-09-01) -
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
by: Yongli Situ, et al.
Published: (2023-09-01) -
SHMT2 Induces Stemness and Progression of Head and Neck Cancer
by: Yanli Jin, et al.
Published: (2022-08-01) -
SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
by: Meihua Jin, et al.
Published: (2021-06-01)